The company have demonstrably boosted the progress of the new therapy for ATTR-CM, leveraging Attruby. Initial trial data reveals significant improvements for those suffering from this severe disease. This effort https://attr-cm317128.aioblogs.com/94856290/bridgebio-advances-amyloidosis-management-using-the-drug